iBio, Inc. Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	0.3	0.4	0.23	-	1.88	2.37
Revenue Growth	-20.00%	77.78%	-	-	-20.54%	44.75%
Cost of Revenue	-	-	-	-	-	1.46
Gross Profit	0.3	0.4	0.23	-	1.88	0.91
Selling, General & Admin	14.95	10.69	11.67	19.02	21.75	22.03
Research & Development	14.31	8.31	5.19	10.33	9.83	9.99
Total Operating Expenses	29.26	19	16.86	29.34	31.58	32.02
Operating Income	-28.96	-18.6	-16.63	-29.34	-29.7	-31.11
Interest Income	1.5	0.44	0.36	0.21	0.18	0.15
Interest Expense	-0.14	-0.21	-0.17	-0.08	-	-2.45
Other Non-Operating Income (Expense)	1.35	0.23	1	-0.1	0.18	10.2
Total Non-Operating Income (Expense)	2.71	0.45	1.19	0.03	0.37	7.9
Pretax Income	-26.25	-18.15	-15.44	-29.31	-29.33	-23.21
Net Income	-5.16	-18.38	-15.44	-29.31	-29.51	-23.21
Minority Interest in Earnings	-	-	-	-	-0	-0.01
Net Income Attributable to Preferred Dividends	-	-	-	-	-0.09	-0.26
Earnings From Discontinued Operations	-	-	-9.46	-35.7	-20.79	-
Net Income to Common	-5.16	-18.38	-24.91	-65.01	-50.39	-23.47
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	72	10	4	1	0	0
Shares Outstanding (Diluted)	72	10	4	1	0	0
Shares Change	690.12%	174.05%	525.98%	40.35%	11.45%	211.53%
EPS (Basic)	-0.57	-1.75	-6.50	-106.19	-115.60	-60.00
EPS (Diluted)	-0.57	-1.75	-6.50	-106.19	-115.60	-60.00
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Free Cash Flow	-22.17	-15.32	-18.55	-36.17	-44.81	-34.98
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.31	-1.46	-4.84	-59.11	-102.76	-89.42
Gross Margin	100.00%	100.00%	100.00%	-	100.00%	38.34%
Operating Margin	-9653.00%	-4650.50%	-7392.89%	-	-1576.27%	-1312.15%
Profit Margin	-1721.00%	-4594.25%	-6863.56%	-	-1566.51%	-979.04%
FCF Margin	-7388.33%	-3830.00%	-8246.22%	-	-2378.45%	-1475.50%
EBITDA	-27.89	-17.48	-15.38	-27.96	-26.21	-28.7
EBITDA Margin	-9298.00%	-4369.00%	-6837.33%	-	-1390.98%	-1210.33%
EBIT	-28.96	-18.6	-16.63	-29.34	-29.7	-31.11
EBIT Margin	-9653.00%	-4650.50%	-7392.89%	-	-1576.27%	-1312.15%

SEC Filings: 10-K · 10-Q